Sponsor: UCLA CTSI ($250,000)
Title: Development of CNS Metastasis Program
Purpose: Interdepartmental seed grant to evaluate the immune response to brain metastases and find novel ways to treat these tumors.
Sponsor: Brain Tumor Funders' Collaborative ($715,000)
Title: Active Vaccination and the Timing of Checkpoint Blockade Dictate Effective Immunotherapy for Glioblastoma
Purpose: Clinical trial in glioblastoma patients with personalized dendritic cell vaccine together with PD-1 checkpoint blockade.
Sponsor: Cancer Research Institute – Clinic and Laboratory Integration Program Award ($200,000)
Title: Elevated TIL accumulation, with clonal TCR expansion and inflammatory tumor gene expression, predict clinical benefit of PD-1 blockade in patients with recurrent glioblastoma
Purpose: To develop new biomarkers for PD-1 blockade in glioblastoma patients.
Donate to UCLA Neurosurgery
UCLA Neurosurgery Development Office Box 956901 Los Angeles, CA 90095-6901